AR083387A1 - Mecanismo de establecimiento de dosis y metodo para utilizar el mismo - Google Patents

Mecanismo de establecimiento de dosis y metodo para utilizar el mismo

Info

Publication number
AR083387A1
AR083387A1 ARP110103764A ARP110103764A AR083387A1 AR 083387 A1 AR083387 A1 AR 083387A1 AR P110103764 A ARP110103764 A AR P110103764A AR P110103764 A ARP110103764 A AR P110103764A AR 083387 A1 AR083387 A1 AR 083387A1
Authority
AR
Argentina
Prior art keywords
dose
establishment
rotating
housing
same
Prior art date
Application number
ARP110103764A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR083387A1 publication Critical patent/AR083387A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
    • A61M5/31551—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe including axial movement of dose setting member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/31561—Mechanically operated dose setting member using freely adjustable volume steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
    • A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
    • A61M5/31585—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod performed by axially moving actuator, e.g. an injection button
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A61M2205/584—Means for facilitating use, e.g. by people with impaired vision by visual feedback having a color code
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A61M2205/585—Means for facilitating use, e.g. by people with impaired vision by visual feedback having magnification means, e.g. magnifying glasses

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente se refiere a un mecanismo de establecimiento de dosis para un dispositivo de administración de dosis y a un método para utilizar el mismo. El mecanismo comprende un alojamiento (205) de dispositivo de administración de fármacos, un componente (104) de selección de dosis situado en el alojamiento (205) y que es giratorio durante el establecimiento de una dosis y la administración de una dosis, un embrague (105) giratorio durante el establecimiento de una dosis y no giratorio durante la administración de una dosis que tiene, situados preferiblemente en un extremo distal, unos dientes (109) de embrague y un anillo (102) de embrague acoplados con el alojamiento (205) en una primera configuración giratoria y en una segunda configuración no giratoria.
ARP110103764A 2010-10-13 2011-10-12 Mecanismo de establecimiento de dosis y metodo para utilizar el mismo AR083387A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39275310P 2010-10-13 2010-10-13
EP11168191 2011-05-31

Publications (1)

Publication Number Publication Date
AR083387A1 true AR083387A1 (es) 2013-02-21

Family

ID=44936626

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110103764A AR083387A1 (es) 2010-10-13 2011-10-12 Mecanismo de establecimiento de dosis y metodo para utilizar el mismo

Country Status (11)

Country Link
US (1) US9616178B2 (es)
EP (1) EP2627377B1 (es)
JP (1) JP5897016B2 (es)
CN (1) CN103260675B (es)
AR (1) AR083387A1 (es)
AU (1) AU2011315626B2 (es)
BR (1) BR112013008882A2 (es)
CA (1) CA2813277A1 (es)
IL (1) IL225679A (es)
TW (1) TWI561271B (es)
WO (1) WO2012049141A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103732278B (zh) * 2011-06-17 2016-02-17 赛诺菲-安万特德国有限公司 用于给药装置的药筒保持器组件
DK3045189T3 (en) 2011-10-14 2018-06-18 Amgen Inc Injector and mounting method
DE202012001410U1 (de) * 2012-02-10 2013-05-13 Haselmeier Gmbh Injektionsgerät
BR112015024282B1 (pt) 2013-03-22 2022-05-17 Amgen Inc Injetor e método de montagem do injetor
US10195357B2 (en) 2013-07-17 2019-02-05 Sanofi Drug delivery device
CN105873626A (zh) 2013-10-24 2016-08-17 美国安进公司 注射器和组装方法
WO2015071212A1 (en) 2013-11-15 2015-05-21 Sanofi-Aventis Deutschland Gmbh Assembly for a drug delivery device and drug delivery device
CN105722541B (zh) 2013-11-15 2019-12-10 赛诺菲-安万特德国有限公司 用于药物输送装置的构件和组件、药物输送装置以及构件的用途
EP2891503A1 (en) * 2014-01-02 2015-07-08 Sanofi-Aventis Deutschland GmbH Assembly for a drug delivery device
EP3006068B1 (en) * 2014-10-09 2020-12-09 Ypsomed AG Medication dispensing apparatus with sub dose prevention
AR102193A1 (es) * 2014-10-09 2017-02-08 Sanofi Sa Manguito impulsor, dispositivo de administración de fármacos y método para ensamblar un dispositivo de administración de fármacos
AU2015372441A1 (en) 2014-12-23 2017-08-10 Automed Pty Ltd Delivery apparatus, system and associated methods
CN107206184B (zh) * 2015-02-10 2021-03-09 赛诺菲-安万特德国有限公司 用于注射装置的驱动机构
JP6739450B2 (ja) * 2015-02-10 2020-08-12 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 注射デバイス用の駆動機構
EP3181169A1 (en) * 2015-12-14 2017-06-21 Sanofi-Aventis Deutschland GmbH Drive mechanism for an injection device
EP3181171A1 (en) * 2015-12-14 2017-06-21 Sanofi-Aventis Deutschland GmbH Drive mechanism for an injection device
CN105944186B (zh) * 2016-05-18 2019-08-02 苏州鹏烨医疗科技有限公司 一种注射笔
CN106039475B (zh) * 2016-05-18 2019-08-02 苏州鹏烨医疗科技有限公司 一种注射笔
US11123493B2 (en) * 2016-05-24 2021-09-21 Sanofi-Aventis Deutschland Gmbh Supplementary device for attachment to a drug delivery device, a number sleeve for a drug delivery device, and a drug delivery device
JP6963573B2 (ja) * 2016-07-01 2021-11-10 サノフイSanofi 薬物送達デバイス
US11554215B2 (en) 2017-06-08 2023-01-17 Novartis Ag Injection device and injection solution transferring system
AU2018319544B2 (en) 2017-08-21 2021-02-25 Eli Lilly And Company Dose detection module for a medication delivery device
MA49946A (fr) 2017-08-21 2020-07-01 Lilly Co Eli Dispositif d'administration de médicament doté d'un système de détection
KR101838953B1 (ko) * 2017-12-22 2018-03-15 (주)메디라인액티브코리아 수액세트용 유량조절기
WO2021122200A1 (en) * 2019-12-18 2021-06-24 Novo Nordisk A/S Fixed dose injection device
US11957542B2 (en) 2020-04-30 2024-04-16 Automed Patent Holdco, Llc Sensing complete injection for animal injection device
KR102256035B1 (ko) * 2020-11-03 2021-05-26 (주)풍림파마텍 도즈 다이얼 사용 중 즉시적인 피드백을 가능하게 하는 약물 투입 조절 장치
KR102271959B1 (ko) * 2020-11-03 2021-07-02 (주)풍림파마텍 도즈 다이얼을 통해 회전력이 가해진 토션 스프링의 꼬임을 일시적으로 유지하게 하는 약물 투입 조절 장치
WO2023203040A1 (en) 2022-04-21 2023-10-26 Sanofi Drive mechanism for an injection device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3715258C2 (de) 1987-05-08 1996-10-31 Haselmeier Wilhelm Fa Injektionsgerät
US5674204A (en) 1995-09-19 1997-10-07 Becton Dickinson And Company Medication delivery pen cap actuated dose delivery clutch
GB0304822D0 (en) * 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
EP1831809A2 (en) 2004-12-08 2007-09-12 Novo Nordisk A/S Device for displaying data relevant for a diabetic patient
CN101163514B (zh) * 2005-04-24 2012-01-25 诺和诺德公司 注射装置
WO2007069121A1 (en) 2005-12-15 2007-06-21 Philips Intellectual Property & Standards Gmbh Advanced convergence for multiple iterative algorithm
ES2416728T3 (es) 2007-12-20 2013-08-02 Novo Nordisk A/S Dispositivo de inyección para administrar una dosis fija de fármaco líquido
DE102008011881A1 (de) * 2008-02-29 2009-09-10 Tecpharma Licensing Ag Leerschießgeschwindigkeitsbegrenzungsbremse
US8647309B2 (en) * 2008-05-02 2014-02-11 Sanofi-Aventis Deutschland Gmbh Medication delivery device
EP2201972A1 (en) 2008-12-23 2010-06-30 Sanofi-Aventis Deutschland GmbH Fixed dose injection device with resettable drive mechanism
US9623187B2 (en) 2009-06-01 2017-04-18 Sanofi-Aventis Deutschland Gmbh Resettable drug delivery device
TW201121600A (en) * 2009-09-29 2011-07-01 Sanofi Aventis Deutschland Assembly for a drug delivery device
DK2482891T3 (en) 2009-09-30 2017-02-06 Sanofi Aventis Deutschland RETRIEVABLE DRIVING AND PHARMACEUTICAL SUPPLY

Also Published As

Publication number Publication date
CN103260675A (zh) 2013-08-21
TW201215424A (en) 2012-04-16
US20130289518A1 (en) 2013-10-31
IL225679A0 (en) 2013-06-27
US9616178B2 (en) 2017-04-11
JP5897016B2 (ja) 2016-03-30
AU2011315626A1 (en) 2013-04-18
EP2627377A1 (en) 2013-08-21
WO2012049141A1 (en) 2012-04-19
AU2011315626B2 (en) 2015-01-22
CN103260675B (zh) 2016-01-20
JP2013539697A (ja) 2013-10-28
CA2813277A1 (en) 2012-04-19
IL225679A (en) 2017-05-29
EP2627377B1 (en) 2019-08-21
BR112013008882A2 (pt) 2017-07-11
TWI561271B (en) 2016-12-11

Similar Documents

Publication Publication Date Title
AR083387A1 (es) Mecanismo de establecimiento de dosis y metodo para utilizar el mismo
AR083379A1 (es) Mecanismo de establecimiento de dosis y metodo para utilizar el mismo
CR7971A (es) Sistema para monitoreo de paciente y suministro de farmaco y metodo de uso
CY1119582T1 (el) Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη
CO6382132A2 (es) Tratamiento de pirfenidona para pacientes con funcion hepatica atipica
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
AR083388A1 (es) Mecanismo de establecimiento de dosis
CL2007001018A1 (es) Inhalador para administrar un medicamento en forma de sustancias inhalables, formulaciones o mezclas de sustancias, comprende una carcasa que presenta un interior para lojar el medicamento, la carcasa esta unida de forma fija a una boquilla, ademas puede incorporar una aguja para perforar una capsula con medicamento.
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
CL2013000477A1 (es) Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides.
AR091876A1 (es) Combinaciones farmaceuticas para el tratamiento de enfermedades proliferativas
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
CL2015001923A1 (es) Uso de crenolanib para el tratamiento de trastornos proliferativos que tiene flt3 mutado
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
BRPI1007732A2 (pt) aparelho para administração de medicamentos para a administração de um aerossol incluindo um medicamento para um paciente, kit para a administração de um aerossol incluindo um medicamento para um paciente e método de administração de um aerossol incluindo um medicamento para um paciente
BR112013020743A2 (pt) composições e métodos para a terapia e diagnóstico de influenza
AR085487A1 (es) Dispositivo de administracion de farmacos
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
CR20140358A (es) Sistema para la administración de fármacos
CL2012002823A1 (es) Composición farmacéutica para el tratamiento de la diabetes y los trastornos relacionados, que comprende un sensibilizador de insulina seleccionado entre pioglitazona y rosiglitazona, glimepirida y metmorfina; formulación farmacéutica oral que la comprende; kit para tratar diabetes tipo ii; y uso de dicha formulación para tratar diabetes.
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria
CL2007000485A1 (es) Sal de alisquereno; procedimiento de preparacion; composicion farmaceutica que comprende a dicha sal; y uso del compuesto para el tratamiento de enfermedades que puedan ser moduladas mediante la inhibicion de la renina.
AR067351A1 (es) Combinacion de picotamida con nafronil

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee